{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T08:00:37Z","timestamp":1789545637517,"version":"build-2803163510"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T00:00:00Z","timestamp":1756512000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T00:00:00Z","timestamp":1756512000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82100220,82370143"],"award-info":[{"award-number":["82100220,82370143"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82100220,82370143"],"award-info":[{"award-number":["82100220,82370143"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Key Provincial-Ministerial Co-construction Project of Henan Province Medical Science and Technology Research Plan","award":["SBGJ202302025"],"award-info":[{"award-number":["SBGJ202302025"]}]},{"name":"Key Provincial-Ministerial Co-construction Project of Henan Province Medical Science and Technology Research Plan","award":["SBGJ202302025"],"award-info":[{"award-number":["SBGJ202302025"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-025-03982-0","type":"journal-article","created":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T12:36:39Z","timestamp":1756557399000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Impact of type 2 and steroid-Induced diabetes mellitus on prognosis in patients with multiple myeloma"],"prefix":"10.1186","volume":"23","author":[{"given":"Ji-Heng","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pu","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Er-Jiang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Na","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Zhang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Jie","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Shan","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bai-Jun","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,30]]},"reference":[{"key":"3982_CR1","volume-title":"Multiple myeloma. Version 3.2023","author":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines)","year":"2022","unstructured":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). Multiple myeloma. Version 3.2023. Fort Washington: National Comprehensice Cancer Network; 2022."},{"issue":"1","key":"3982_CR2","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.mayocp.2015.11.007","volume":"91","author":"SV Rajkumar","year":"2016","unstructured":"Rajkumar SV, Kumar S. Multiple myeloma: diagnosis and treatment. Mayo Clin Proc. 2016;91(1):101\u201319. https:\/\/doi.org\/10.1016\/j.mayocp.2015.11.007.","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"3982_CR3","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.annonc.2020.11.014","volume":"32","author":"MA Dimopoulos","year":"2021","unstructured":"Dimopoulos MA, Moreau P, Terpos E, Mateos MV, Zweegman S, Cook G, et al. Multiple myeloma: EHA-ESMO clinical practice guidelines for diagnosis, treatment and follow-up(dagger). Ann Oncol. 2021;32(3):309\u201322. PubMed PMID: 33549387.","journal-title":"Ann Oncol"},{"issue":"6","key":"3982_CR4","first-page":"422","volume":"64","author":"G Bianchi","year":"2014","unstructured":"Bianchi G, Anderson KC. Understanding biology to tackle the disease: multiple myeloma from bench to bedside, and back. CA Cancer J Clin. 2014;64(6):422\u201344.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"3982_CR5","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1056\/NEJMoa0708704","volume":"359","author":"HT Lynch","year":"2008","unstructured":"Lynch HT, Ferrara K, Barlogie B, Coleman EA, Lynch JF, Weisenburger D, et al. Familial myeloma. N Engl J Med. 2008;359(2):152\u20137. https:\/\/doi.org\/10.1056\/NEJMoa0708704.","journal-title":"N Engl J Med"},{"issue":"6","key":"3982_CR6","doi-asserted-by":"publisher","first-page":"984","DOI":"10.3324\/haematol.2013.100552","volume":"99","author":"NW van de Donk","year":"2014","unstructured":"van de Donk NW, Palumbo A, Johnsen HE, Engelhardt M, Gay F, Gregersen H, et al. The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European myeloma network. Haematologica. 2014;99(6):984\u201396. PubMed PMID: 24658815; PubMed Central PMCID: PMCPMC4040895.","journal-title":"Haematologica"},{"issue":"10125","key":"3982_CR7","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S0140-6736(17)33326-3","volume":"391","author":"C Allemani","year":"2018","unstructured":"Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Niksic M, et al. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391(10125):1023\u201375. https:\/\/doi.org\/10.1016\/S0140-6736(17)33326-3. Epub 2018\/02\/06.","journal-title":"Lancet"},{"issue":"12","key":"3982_CR8","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.2215\/CJN.01640216","volume":"11","author":"KW Finkel","year":"2016","unstructured":"Finkel KW, Cohen EP, Shirali A, Abudayyeh A. American society of nephrology Onco-Nephrology F. Paraprotein-Related kidney disease: evaluation and treatment of myeloma cast nephropathy. Clin J Am Soc Nephrol. 2016;11(12):2273\u20139. 01640216. PubMed PMID: 27526708; PubMed Central PMCID: PMCPMC5142056.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"11","key":"3982_CR9","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1517\/14656566.2013.803068","volume":"14","author":"E Kastritis","year":"2013","unstructured":"Kastritis E, Terpos E, Dimopoulos MA. Current treatments for renal failure due to multiple myeloma. Expert Opin Pharmacother. 2013;14(11):1477\u201395. https:\/\/doi.org\/10.1517\/14656566.2013.803068.","journal-title":"Expert Opin Pharmacother"},{"issue":"13","key":"3982_CR10","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1182\/blood-2014-12-615187","volume":"125","author":"A Palumbo","year":"2015","unstructured":"Palumbo A, Bringhen S, Mateos MV, Larocca A, Facon T, Kumar SK, et al. Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an international myeloma working group report. Blood. 2015;125(13):2068\u201374. https:\/\/doi.org\/10.1182\/blood-2014-12-615187.","journal-title":"Blood"},{"issue":"3","key":"3982_CR11","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/bjh.14304","volume":"175","author":"D Smith","year":"2016","unstructured":"Smith D, Yong K. Advances in understanding prognosis in myeloma. Br J Haematol. 2016;175(3):367\u201380. https:\/\/doi.org\/10.1111\/bjh.14304.","journal-title":"Br J Haematol"},{"issue":"4","key":"3982_CR12","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1183\/09031936.00059814","volume":"44","author":"MJ Divo","year":"2014","unstructured":"Divo MJ, Martinez CH, Mannino DM. Ageing and the epidemiology of multimorbidity. Eur Respir J. 2014;44(4):1055\u201368. https:\/\/doi.org\/10.1183\/09031936.00059814.","journal-title":"Eur Respir J"},{"key":"3982_CR13","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.2147\/IJGM.S309783","volume":"14","author":"ZY Fan","year":"2021","unstructured":"Fan ZY, Yang Y, Zhang CH, Yin RY, Tang L, Zhang F. Prevalence and patterns of comorbidity among Middle-Aged and elderly people in china: A Cross-Sectional study based on CHARLS data. Int J Gen Med. 2021;14:1449\u201355. PubMed PMID: 33907449; PubMed Central PMCID: PMCPMC8071077.","journal-title":"Int J Gen Med"},{"issue":"Suppl 1","key":"3982_CR14","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.2337\/dc23-Sint","volume":"46","author":"NA ElSayed","year":"2023","unstructured":"ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, et al. Introduction and methodology: standards of care in Diabetes-2023. Diabetes Care. 2023;46(Suppl 1):S1\u20134. https:\/\/doi.org\/10.2337\/dc23-Sint. Epub 2022\/12\/13.","journal-title":"Diabetes Care"},{"issue":"10085","key":"3982_CR15","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1016\/S0140-6736(17)30058-2","volume":"389","author":"S Chatterjee","year":"2017","unstructured":"Chatterjee S, Khunti K, Davies MJ. Type 2 diabetes. Lancet. 2017;389(10085):2239\u201351. https:\/\/doi.org\/10.1016\/S0140-6736(17)30058-2.","journal-title":"Lancet"},{"key":"3982_CR16","volume-title":"Corticosteroids","author":"A Hodgens","year":"2023","unstructured":"Hodgens A, Sharman T. Corticosteroids. Treasure Island (FL): StatPearls; 2023."},{"issue":"Suppl 1","key":"3982_CR17","doi-asserted-by":"publisher","first-page":"S81","DOI":"10.2337\/dc14-S081","volume":"37","author":"A American Diabetes","year":"2014","unstructured":"American Diabetes A. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014;37(Suppl 1):S81\u201390. https:\/\/doi.org\/10.2337\/dc14-S081. Epub 2013\/12\/21.","journal-title":"Diabetes Care"},{"issue":"2","key":"3982_CR18","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1002\/dmrr.2486","volume":"30","author":"JL Hwang","year":"2014","unstructured":"Hwang JL, Weiss RE. Steroid-induced diabetes: a clinical and molecular approach to understanding and treatment. Diabetes Metab Res Rev. 2014;30(2):96\u2013102. https:\/\/doi.org\/10.1002\/dmrr.2486.","journal-title":"Diabetes Metab Res Rev"},{"issue":"4","key":"3982_CR19","doi-asserted-by":"publisher","first-page":"358","DOI":"10.4158\/EP.12.4.358","volume":"12","author":"AC Donihi","year":"2006","unstructured":"Donihi AC, Raval D, Saul M, Korytkowski MT, DeVita MA. Prevalence and predictors of corticosteroid-related hyperglycemia in hospitalized patients. Endocr Pract. 2006;12(4):358\u201362. https:\/\/doi.org\/10.4158\/EP.12.4.358.","journal-title":"Endocr Pract"},{"issue":"5","key":"3982_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3535","volume":"38","author":"A Tentolouris","year":"2022","unstructured":"Tentolouris A, Ntanasis-Stathopoulos I, Eleftheriadou I, Malandrakis P, Tzeravini E, Gavriatopoulou M. Diabetes mellitus and multiple myeloma; common features of two distinct entities. Diabetes Metab Res Rev. 2022;38(5): e3535. https:\/\/doi.org\/10.1002\/dmrr.3535.","journal-title":"Diabetes Metab Res Rev"},{"issue":"3","key":"3982_CR21","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/bjc.2014.307","volume":"111","author":"W Wu","year":"2014","unstructured":"Wu W, Merriman K, Nabaah A, Seval N, Seval D, Lin H, et al. The association of diabetes and anti-diabetic medications with clinical outcomes in multiple myeloma. Br J Cancer. 2014;111(3):628\u201336. https:\/\/doi.org\/10.1038\/bjc.2014.307.","journal-title":"Br J Cancer"},{"issue":"6","key":"3982_CR22","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1111\/j.1365-2141.2008.07573.x","volume":"144","author":"PG Richardson","year":"2009","unstructured":"Richardson PG, Sonneveld P, Schuster MW, Stadtmauer EA, Facon T, Harousseau JL, et al. Reversibility of symptomatic peripheral neuropathy with bortezomib in the phase III APEX trial in relapsed multiple myeloma: impact of a dose-modification guideline. Br J Haematol. 2009;144(6):895\u2013903. https:\/\/doi.org\/10.1111\/j.1365-2141.2008.07573.x.","journal-title":"Br J Haematol"},{"issue":"19","key":"3982_CR23","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.1200\/JCO.2005.04.7779","volume":"24","author":"PG Richardson","year":"2006","unstructured":"Richardson PG, Briemberg H, Jagannath S, Wen PY, Barlogie B, Berenson J, et al. Frequency, characteristics, and reversibility of peripheral neuropathy during treatment of advanced multiple myeloma with bortezomib. J Clin Oncol. 2006;24(19):3113\u201320. https:\/\/doi.org\/10.1200\/JCO.2005.04.7779.","journal-title":"J Clin Oncol"},{"issue":"4","key":"3982_CR24","doi-asserted-by":"publisher","first-page":"931","DOI":"10.2337\/dc09-1721","volume":"33","author":"BB Barone","year":"2010","unstructured":"Barone BB, Yeh HC, Snyder CF, Peairs KS, Stein KB, Derr RL, et al. Postoperative mortality in cancer patients with preexisting diabetes: systematic review and meta-analysis. Diabetes Care. 2010;33(4):931\u20139. https:\/\/doi.org\/10.2337\/dc09-1721. Epub 2010\/03\/31.","journal-title":"Diabetes Care"},{"issue":"23","key":"3982_CR25","doi-asserted-by":"publisher","first-page":"2754","DOI":"10.1001\/jama.2008.824","volume":"300","author":"BB Barone","year":"2008","unstructured":"Barone BB, Yeh HC, Snyder CF, Peairs KS, Stein KB, Derr RL, et al. Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. JAMA. 2008;300(23):2754\u201364. PubMed PMID: 19088353; PubMed Central PMCID: PMCPMC3093051.","journal-title":"JAMA"},{"issue":"3","key":"3982_CR26","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1007\/s00125-020-05338-7","volume":"64","author":"IY Gong","year":"2021","unstructured":"Gong IY, Cheung MC, Read S, Na Y, Lega IC, Lipscombe LL. Association between diabetes and haematological malignancies: a population-based study. Diabetologia. 2021;64(3):540\u201351. https:\/\/doi.org\/10.1007\/s00125-020-05338-7.","journal-title":"Diabetologia"},{"issue":"12","key":"3982_CR27","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1158\/1055-9965.EPI-06-0007","volume":"15","author":"BC Chiu","year":"2006","unstructured":"Chiu BC, Gapstur SM, Greenland P, Wang R, Dyer A. Body mass index, abnormal glucose metabolism, and mortality from hematopoietic cancer. Cancer Epidemiol Biomarkers Prev. 2006;15(12):2348\u201354. https:\/\/doi.org\/10.1158\/1055-9965.EPI-06-0007.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"6","key":"3982_CR28","doi-asserted-by":"publisher","first-page":"842","DOI":"10.3324\/haematol.12297","volume":"93","author":"AE Khan","year":"2008","unstructured":"Khan AE, Gallo V, Linseisen J, Kaaks R, Rohrmann S, Raaschou-Nielsen O, et al. Diabetes and the risk of non-Hodgkin\u2019s lymphoma and multiple myeloma in the European prospective investigation into cancer and nutrition. Haematologica. 2008;93(6):842\u201350. https:\/\/doi.org\/10.3324\/haematol.12297.","journal-title":"Haematologica"},{"key":"3982_CR29","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/461917","author":"W Duan","year":"2014","unstructured":"Duan W, Shen X, Lei J, Xu Q, Yu Y, Li R, et al. Hyperglycemia, a neglected factor during cancer progression. Biomed Res Int. 2014. https:\/\/doi.org\/10.1155\/2014\/461917. 2014:461917. Epub 2014\/05\/28.","journal-title":"Biomed Res Int"},{"issue":"7","key":"3982_CR30","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/j.bbmt.2017.03.012","volume":"23","author":"L Sanchez","year":"2017","unstructured":"Sanchez L, Sylvester M, Parrondo R, Mariotti V, Eloy JA, Chang VT. In-hospital mortality and post-transplantation complications in elderly multiple myeloma patients undergoing autologous hematopoietic stem cell transplantation: a population-based study. Biol Blood Marrow Transpl. 2017;23(7):1203\u20137. https:\/\/doi.org\/10.1016\/j.bbmt.2017.03.012.","journal-title":"Biol Blood Marrow Transpl"},{"issue":"1","key":"3982_CR31","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2016-000336","volume":"5","author":"W Abu-Ashour","year":"2017","unstructured":"Abu-Ashour W, Twells L, Valcour J, Randell A, Donnan J, Howse P, et al. The association between diabetes mellitus and incident infections: a systematic review and meta-analysis of observational studies. BMJ Open Diabetes Res Care. 2017;5(1): e000336. https:\/\/doi.org\/10.1136\/bmjdrc-2016-000336.","journal-title":"BMJ Open Diabetes Res Care"},{"key":"3982_CR32","doi-asserted-by":"publisher","first-page":"413149","DOI":"10.1155\/2014\/413149","volume":"2014","author":"SH Jung","year":"2014","unstructured":"Jung SH, Jang HC, Lee SS, Ahn JS, Yang DH, Kim YK, et al. The impact of hyperglycemia on risk of severe infections during early period of induction therapy in patients with newly diagnosed multiple myeloma. Biomed Res Int. 2014;2014:413149. https:\/\/doi.org\/10.1155\/2014\/413149. Epub 2014\/05\/14.","journal-title":"Biomed Res Int"},{"issue":"1","key":"3982_CR33","doi-asserted-by":"publisher","first-page":"e30","DOI":"10.1016\/S2352-3026(14)00037-4","volume":"2","author":"SH Chang","year":"2015","unstructured":"Chang SH, Luo S, O\u2019Brian KK, Thomas TS, Colditz GA, Carlsson NP, et al. Association between Metformin use and progression of monoclonal gammopathy of undetermined significance to multiple myeloma in US veterans with diabetes mellitus: a population-based retrospective cohort study. Lancet Haematol. 2015;2(1):e30\u20136. https:\/\/doi.org\/10.1016\/S2352-3026(14)00037-4. Epub 2015\/06\/03.","journal-title":"Lancet Haematol"},{"issue":"12","key":"3982_CR34","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.6004\/jnccn.2020.0057","volume":"18","author":"SK Kumar","year":"2020","unstructured":"Kumar SK, Callander NS, Adekola K, Anderson L, Baljevic M, Campagnaro E, et al. Multiple myeloma, version 3.2021, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2020;18(12):1685\u2013717. https:\/\/doi.org\/10.6004\/jnccn.2020.0057.","journal-title":"J Natl Compr Canc Netw"},{"issue":"8","key":"3982_CR35","doi-asserted-by":"publisher","first-page":"e328","DOI":"10.1016\/S1470-2045(16)30206-6","volume":"17","author":"S Kumar","year":"2016","unstructured":"Kumar S, Paiva B, Anderson KC, Durie B, Landgren O, Moreau P, et al. International myeloma working group consensus criteria for response and minimal residual disease assessment in multiple myeloma. Lancet Oncol. 2016;17(8):e328\u201346. 16)30206-6. PubMed PMID: 27511158.","journal-title":"Lancet Oncol"},{"issue":"9","key":"3982_CR36","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1038\/sj.leu.2404284","volume":"20","author":"BG Durie","year":"2006","unstructured":"Durie BG, Harousseau JL, Miguel JS, Blade J, Barlogie B, Anderson K, et al. International uniform response criteria for multiple myeloma. Leukemia. 2006;20(9):1467\u201373. https:\/\/doi.org\/10.1038\/sj.leu.2404284.","journal-title":"Leukemia"},{"key":"3982_CR37","volume-title":"Classification of diabetes mellitus 2019","author":"World Health Organization","year":"2019","unstructured":"World Health Organization. Classification of diabetes mellitus 2019. Geneva: World Health Organization; 2019."},{"key":"3982_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13225735","author":"RK Shahid","year":"2021","unstructured":"Shahid RK, Ahmed S, Le D, Yadav S. Diabetes and cancer: risk, challenges, management and outcomes. Cancers (Basel). 2021. https:\/\/doi.org\/10.3390\/cancers13225735.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"3982_CR39","doi-asserted-by":"publisher","first-page":"2179218","DOI":"10.1080\/16078454.2023.2179218","volume":"28","author":"ZY Dou","year":"2023","unstructured":"Dou ZY, Xia B, Wang CY, Xu YJ, Zhang YZ. Influence of diabetes mellitus on the biochemical parameters and outcomes of multiple myeloma. Hematology. 2023;28(1):2179218. PubMed PMID: 36799658.","journal-title":"Hematology"},{"issue":"2","key":"3982_CR40","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1056\/NEJMoa2204925","volume":"387","author":"PG Richardson","year":"2022","unstructured":"Richardson PG, Jacobus SJ, Weller EA, Hassoun H, Lonial S, Raje NS, et al. Triplet therapy, transplantation, and maintenance until progression in myeloma. N Engl J Med. 2022;387(2):132\u201347. https:\/\/doi.org\/10.1056\/NEJMoa2204925.","journal-title":"N Engl J Med"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-03982-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-025-03982-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-03982-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T22:40:28Z","timestamp":1757457628000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-025-03982-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,30]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3982"],"URL":"https:\/\/doi.org\/10.1186\/s12957-025-03982-0","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,30]]},"assertion":[{"value":"19 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study is a retrospective clinical analysis, which does not involve scientific research on animals, humans, human derived samples, and human embryonic stem cells. Ethical proof is not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"330"}}